ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
819 hedge funds and large institutions have $31.3B invested in Alexion Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 202 funds opening new positions, 239 increasing their positions, 283 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
16% more funds holding
Funds holding: 704 → 819 (+115)
16% less repeat investments, than reductions
Existing positions increased: 239 | Existing positions reduced: 283
Holders
819
Holding in Top 10
46
Calls
$559M
Puts
$436M
Top Buyers
| 1 | +$463M | |
| 2 | +$351M | |
| 3 | +$329M | |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
+$269M |
| 5 |
Millennium Management
New York
|
+$256M |
Top Sellers
| 1 | -$548M | |
| 2 | -$430M | |
| 3 | -$315M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$247M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$233M |